5
TAVEXIA LIFECARE
MAYUKHDEALTRADELTD NSE
TAVEXIA LIFECARE
RetailNSE: MAYUKHDEALTRADELTD BSE: 539519 Distributors
Key Fundamentals
MicrocapDistributorsRetailMarket Cap
₹42.15 Cr
Volatility
High Risk
P/E Ratio
-53.5
EBITDA
₹-5.13 Cr
Return on Equity
10.39%
Debt to Equity
0.08
Book Value
₹1.13
EPS
₹0.64
52W High
₹1.14
52W Low
₹0.49
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
3- Company is almost debt free.
- Stock is trading at 0.99 times its book value
- Debtor days have improved from 341 to 125 days.
Weaknesses
4- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Promoter holding is low: 6.39%
- Company has a low return on equity of 5.03% over last 3 years.
Growth Rate
Revenue Growth
466% higher than
3Y
Net Income Growth
-97.2% lower than
3Y
Cash Flow Change
104% lower than
3Y
ROE
93.84% higher than
3Y
ROCE
90.24% lower than
3Y
EBITDA Margin (Avg.)
-121% higher than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.59 | 0.46 | 1.52 | 0.79 | 0.7 | 1.56 | 1.96 | 1.05 | 1.22 | 16.84 | 5.69 | 8.5 | 0.64 |
| Expenses | 0.35 | 0.03 | 0.93 | 0.33 | 0.21 | 0.64 | 0.9 | 0.27 | 0.44 | 15.68 | 6.23 | 15.03 | 0.88 |
| Operating Profit | 0.24 | 0.43 | 0.59 | 0.46 | 0.49 | 0.92 | 1.06 | 0.78 | 0.78 | 1.16 | -0.54 | -6.53 | -0.24 |
| OPM % | 40.68% | 93.48% | 38.82% | 58.23% | 70% | 58.97% | 54.08% | 74.29% | 63.93% | 6.89% | -9.49% | -76.82% | -37.5% |
| Other Income | 0 | 0 | 0 | 0 | 0.1 | 0.04 | 0 | 0.26 | 0 | 0.04 | 0 | 5.85 | 0.12 |
| Interest | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.05 |
| Depreciation | 0.13 | 0.09 | 0.08 | 0.18 | 0.1 | 0.1 | 0.09 | 0.12 | 0.08 | 0.13 | 0.16 | 0.18 | 0.14 |
| PBT | 0.11 | 0.34 | 0.51 | 0.28 | 0.48 | 0.85 | 0.96 | 0.91 | 0.69 | 1.06 | -0.71 | -0.87 | -0.31 |
| Tax % | 27.27% | 20.59% | 25.49% | 75% | 27.08% | 27.06% | 27.08% | 7.69% | 5.8% | 25.47% | -1.41% | -18.39% | -48.39% |
| Net Profit | 0.08 | 0.27 | 0.38 | 0.06 | 0.34 | 0.62 | 0.69 | 0.84 | 0.65 | 0.78 | -0.7 | -0.71 | -0.16 |
| EPS in Rs | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.02 | 0.02 | -0.01 | -0.01 | 0 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 0.43 | 1.29 | 1.54 | 2.21 | 3.55 | 5.26 | 32.25 | 31.67 |
| Expenses | 0.36 | 0.63 | 1.44 | 1.14 | 1.58 | 1.97 | 37.38 | 37.82 |
| Operating Profit | 0.07 | 0.66 | 0.1 | 1.07 | 1.97 | 3.29 | -5.13 | -6.15 |
| OPM % | 16.28% | 51.16% | 6.49% | 48.42% | 55.49% | 62.55% | -15.91% | -19.42% |
| Other Income | 0 | 0 | 0 | -0.06 | -0.03 | 0.37 | 5.89 | 6.01 |
| Interest | 0.06 | 0.05 | 0.02 | 0.03 | 0.02 | 0.05 | 0.04 | 0.08 |
| Depreciation | 0.01 | 0.02 | 0.06 | 0.22 | 0.38 | 0.42 | 0.55 | 0.61 |
| PBT | 0 | 0.59 | 0.02 | 0.76 | 1.54 | 3.19 | 0.17 | -0.83 |
| Tax % | — | 25.42% | 0% | 27.63% | 22.08% | 21.94% | -23.53% | — |
| Net Profit | 0 | 0.44 | 0.02 | 0.55 | 1.19 | 2.49 | 0.21 | -0.79 |
| EPS in Rs | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 |
| Div. Payout % | — | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | — | 3.2 | 3.2 | 8.05 | 12.05 | 19.25 | 38.36 |
| Reserves | — | 0.44 | 0.51 | 7.43 | 10.14 | 4.71 | 4.87 |
| Borrowings | — | 0.1 | 0.1 | 0.24 | 0.17 | 0.52 | 3.5 |
| Other Liabilities | — | 0.51 | 0.64 | 0.64 | 0.92 | 2.15 | 64.62 |
| Total Liabilities | — | 4.25 | 4.45 | 16.36 | 23.28 | 26.63 | 111 |
| Fixed Assets | — | 0 | 0.15 | 1.51 | 1.13 | 1.15 | 3.79 |
| CWIP | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | — | 0 | 0.03 | 8.13 | 10.89 | 10.89 | 12.75 |
| Other Assets | — | 4.25 | 4.27 | 6.72 | 11.26 | 14.59 | 94.81 |
| Total Assets | — | 4.25 | 4.45 | 16.36 | 23.28 | 26.63 | 111 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | — | -0.59 | -0.92 | -1.47 | -2.77 | 0.11 | -14.34 |
| Investing | — | -0.08 | 0.73 | -9.68 | -2.77 | -0.48 | -3.61 |
| Financing | — | 0.87 | 0.03 | 11.16 | 5.51 | 0.37 | 19.32 |
| Net Cash Flow | — | 0.2 | -0.16 | 0.01 | -0.03 | 0 | 1.37 |
| Free Cash Flow | — | -0.67 | -1.14 | -3.05 | -2.77 | -0.37 | -17.53 |
| CFO/OP | — | -89 | -920 | -118 | -123 | 25 | 281 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | — | 385 | 457 | 499 | 512 | 385 | 125 |
| Inventory Days | — | 1,460 | 543 | 2,579 | 1,035 | 2,404 | 81.13 |
| Days Payable | — | 539 | 173 | 412 | 181 | 529 | 581 |
| Cash Conversion Cycle | — | 1,306 | 827 | 2,665 | 1,366 | 2,260 | -375 |
| Working Capital Days | — | 450 | 822 | 960 | 1,039 | 843 | 285 |
| ROCE % | — | — | 1.06% | 8.7% | 8.35% | 13.79% | 0.59% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view TAVEXIA LIFECARE insights
58 extracted metrics + investor summaries across FY12–FY26.
Documents
2
Announcement under Regulation 30 (LODR)-Newspaper Publication
12 Sep - We are submitting herewith a copy of Newspaper Publication Regarding sending of 46th Annual Report to shareholder and Remote E-voting facilities. 12 Sep - We are submitting herewith a copy of Newspaper Publication Regarding sending of 46th Annual Report to shareholder and Remote E-voting facilities.
3
Board Meeting Outcome for Outcome Of Board Meeting
24 Apr - Board appointed Sachin Manseta as independent director and Chirag Dedhia as non-independent director effective 24 April 2026. 24 Apr - Board appointed Sachin Manseta as independent director and Chirag Dedhia as non-independent director effective 24 April 2026.
4
Announcement under Regulation 30 (LODR)-Change in Management
24 Apr - Board appointed Sachin Manseta as independent director and Chirag Dedhia as non-independent director on 24 April 2026. 24 Apr - Board appointed Sachin Manseta as independent director and Chirag Dedhia as non-independent director on 24 April 2026.
5
Board Meeting Outcome for Outcome Of Board Meeting
15h - Board appointed Sachin Manseta as independent director and Chirag Dedhia as non-independent director effective 24 April 2026. 15h - Board appointed Sachin Manseta as independent director and Chirag Dedhia as non-independent director effective 24 April 2026.
Frequently Asked Questions about TAVEXIA LIFECARE
What does TAVEXIA LIFECARE LIMITED do?
Incorporated in 1980, Sattva Sukun Lifecare Ltd is in the business of the manufacturing & trading of Burners[1]
Where is TAVEXIA LIFECARE LIMITED (539519) listed?
TAVEXIA LIFECARE LIMITED trades as MAYUKHDEALTRADELTD on the NSE and under code 539519 on the BSE.
Which sector does TAVEXIA LIFECARE LIMITED belong to?
TAVEXIA LIFECARE LIMITED is classified under the Retail sector, in the Distributors industry.
What is the market capitalisation of TAVEXIA LIFECARE LIMITED?
TAVEXIA LIFECARE LIMITED has a market capitalisation of ₹42.15 Cr, which places it in the Small Cap band.
What is the PE ratio of TAVEXIA LIFECARE LIMITED?
TAVEXIA LIFECARE LIMITED trades at a PE ratio of -53.50, on earnings per share of ₹0.64, against a book value of ₹1.13 per share.
What is the 52-week high and low of TAVEXIA LIFECARE LIMITED?
Over the last 52 weeks TAVEXIA LIFECARE LIMITED has traded between ₹0.49 and ₹1.14.
What is the Return on Equity (ROE) of TAVEXIA LIFECARE LIMITED?
TAVEXIA LIFECARE LIMITED reported a return on equity of 10.39%. Its debt-to-equity ratio is 0.08.
Company Information
Incorporated in 1980, Sattva Sukun Lifecare Ltd is in the business of the manufacturing & trading of Burners[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539519.md for TAVEXIA LIFECARE LIMITED: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.